CRGT - Cortigent Medical Net earnings per share (EPS TTM)

CRGT (Cortigent, Inc.) - company brandmark

Cortigent, Inc. develops neural interfaces to restore motor control and vision for injured individuals. The rolling specific profit history confirms the dynamics of this process, where indicates the value of this parameter. High R&D barriers and unique microelectrode implantation methods provide the company with a technological edge. A stable operating environment is supported by the humanitarian status of biomedicine, which minimizes geopolitical risks.

CRGT (Cortigent Medical) Net earnings per share for the trailing year history from 07/04/2022 to 11/14/2026

Financial and market metric breakdowns for cortigent.com (CRGT)

- share price and expert price forecast:
Stock Quotes Cortigent Medical|CRGT - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Cortigent|CRGT - Company Buyout Price
- business book valuation details:
Book Value per Share Cortigent|CRGT - Book Value of Business|Market Capitalization to Book Value Ratio cortigent.com|CRGT - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Cortigent, Inc.|CRGT - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Cortigent Medical|CRGT - Company Cumulative Indebtedness|Debt to Book Value CRGT|CRGT - Company Long-Term Loans and Borrowings|Company Short-Term Debts Cortigent|Quick Liquidity cortigent.com
- net income and valuation multiples indicators:
CRGT - Company Profit|Projected Future Earnings Cortigent, Inc.|CRGT - Price to Earnings Ratio|Projected Price to Earnings Cortigent Inc|CRGT - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple CRGT|CRGT - Operating profit before deduction of amortization|Earnings per share for the last twelve months Cortigent|CRGT - Earnings per share for the trailing year|Quarterly EPS earnings growth cortigent.com|CRGT - Net earnings per share change in current year|Expected earnings per share growth for next year Cortigent, Inc.
- sales volume and revenue indicators:
CRGT - Company Total Sales|Company Projected Revenue Cortigent Inc|CRGT - Market Cap to Revenue Ratio|Forward P/S Multiple Cortigent, Inc.
Summary company analytics:Cortigent Medical - CRGT
Mass-produced product of Cortigent, Inc.

Net income per share over 12 months measures the actual efficiency of capital by distributing total annual income among all security holders. The dynamics of this metric allow an investor to assess business growth rates regardless of share issuance. An analysis of net income per share over the last four quarters reveals the ability of Cortigent, Inc. (CRGT) to monetize its developments. This chart reflects the financial results of implementing neurostimulation systems into medical practice. The stability of the line confirms the successful commercialization of brain-computer interfaces.

Competing companies

biogen.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NBIX (Neurocrine)|RGC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Axsome Therapeutics Inc|ACAD (ACADIA Corp) - Net earnings per share (EPS TTM)|XENE: Earnings per share for the trailing year|Net earnings per share for the last 12 months VKTX (Viking Therapeutics, Inc.)|Net earnings per share (EPS TTM) Supernus Pharmaceuticals, Inc. (SUPN)|Catalyst Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters DNLI (Denali Therapeutics Inc)|Harmony Biosciences - Net earnings per share (EPS TTM)|Earnings per share for the trailing year BHVN (biohavenpharma.com)|AMLX: Net earnings per share (EPS TTM)|Trevi Therapeutics, Inc. - Earnings per share for the trailing year|PRAX (Praxis Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Anavex Life Sciences AVXL|Net earnings per share (EPS TTM) CBLL|PRTA (prothena.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALEC (Alector Inc.)|Net earnings per share (EPS TTM) Annexon Biosciences ANNX|Omeros Corporation - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Neurogene Therapeutics NGNE|ACIU: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Voyager Therapeutics, Inc. (VYGR)|Net earnings per share for the last 12 months NMRA|Net earnings per share for the last 12 months Scilex Holding (SCLX)|Net earnings per share (EPS TTM) TVGN|Net earnings per share for the last 12 months Alpha Cognition Inc ACOG|cogrx.com - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Inhibikase Therapeutics, Inc. IKT|SAVA - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Assertio ASRT|Coya Therapeutics, Inc. (COYA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months VistaGen Therapeutics Inc|OVID (ovidrx.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ABOS|Earnings per share for the last twelve months CervoMed Corporation (CRVO)|Net earnings per share (EPS TTM) Alterity Therapeutics Ltd (ATHE)|Earnings per share for the last twelve months clene.com CLNN|PEPG (PepGen Corp) - Earnings per one share for the last 12 months|JUNS - Earnings per share for the last twelve months|RLMD (relmada.com) - Earnings per share for the last 12 months|Annovis Bio Corporation (ANVS) - Earnings per share for the last twelve months|Grace Therapeutics Inc - Earnings per share for the trailing year|AIFF (Firefly Neuro) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months KLTO|Earnings per share for the last twelve months NeuroSense Therapeutics, Ltd. (NRSN)|Reviva Pharmaceuticals - Earnings per share for the last 12 months|MetaVia Inc - Net earnings per share for the last 12 months|NRXS: Earnings per share for the last 12 months|HSDT - Earnings per share for the last twelve months|Net earnings per share for the last four quarters passagebio.com PASG|NEUP (Neuphoria Therapeutics) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months minervaneurosciences.com (NERV)|ATHA (Athira Pharma Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Addex Therapeutics, Ltd. ADXN|Net earnings per share (EPS TTM) ALZN|Net earnings per share for the last 12 months Cyclerion CYCN|Earnings per share for the last twelve months Protagenic Therapeutics Inc. PTIX|Net earnings per share for the last four quarters Pasithea (KTTA)|Avenue Therapeutics Inc - Net earnings per share (EPS TTM)|Brainstorm Cell Therapeutics, Inc. (BCLI) - Net earnings per share for the last 12 months|CARA: Net earnings per share (EPS TTM)|Chromocell - Earnings per share for the trailing year|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|ITCI (intracellulartherapies.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Longboard Pharma (LBPH)|Marinus - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NKGN (nkgenbiotech.com)|NeuroBo Pharma - Earnings per share for the last twelve months|Sage Therapeutics Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year SNPX (Synaptogenix, Inc.)|TRVN (trevena.com) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Vigil Neuroscience Inc.|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year